There has been no shortage of news across the diabetes and drug delivery markets over the course of 2024. At Drug Delivery Business News, we’ve tried to cover it all. From product launches to major regulatory nods — with significant partnerships and integrations in between — diabetes technology particularly dominated the news over the last 12 […]
Dexcom
Oura raises $200M from investors including Dexcom
Oura announced today that it completed a $200 million Series D funding round that included Dexcom (Nasdaq:DXCM). The investment comes as part of a new health monitoring partnership between the continuous glucose monitor (CGM) maker and Oura, the maker of smart ring technology. Fidelity Management & Research Co. also contributed to the financing. San Francisco–based Oura says the financing round […]
Dexcom launches generative AI platform for glucose biosensing
Dexcom (Nasdaq:DXCM) announced today that it launched a proprietary generative AI platform integrated with its glucose biosensing technology. San Diego-based Dexcom says this makes it the first continuous glucose monitor (CGM) manufacturer to integrate GenAI into this technology. The new platform analyzes individual health data patterns. It could reveal a direct association between lifestyle choices […]
European court rules in favor of Abbott in Dexcom CGM patent spat
The Unified Patent Court in Paris sided with Abbott (NYSE:ABT) following a CGM patent infringement claim from Dexcom (Nasdaq:DXCM). Abbott and Dexcom are two leaders in the continuous glucose monitoring (CGM) space. They offer market-leading platforms, with Abbott’s FreeStyle Libre 3 and Dexcom’s G7 representing their latest-generation technologies. Dexcom requested that the court find infringement […]
Tandem makes t:slim X2 insulin pump available with Dexcom G7 in Canada
Tandem Diabetes Care (Nasdaq:TNDM) announced today that t:slim X2 insulin pump users in Canada can now access full compatibility with Dexcom (Nasdaq:DXCM) CGMs. Following authorization from Health Canada, in-warranty pump users can access full compatibility with the G7 and G6 CGMs. This makes t:slim X2 the first and only pump integrated with both continuous glucose […]
Dexcom invests $75M in Oura as companies strike health monitoring partnership
Dexcom (Nasdaq:DXCM) announced today that it entered into a strategic partnership with Oura, maker of leading smart ring technology. The partnership aims to help people improve their metabolic health by integrating Dexcom glucose data with vital sign, sleep, stress, heart health and activity data from the Oura Ring. Combining glucose data with biometrics can deliver […]
The biggest diabetes tech stories of the year so far
On World Diabetes Day, it’s worth taking a look back at the last 10.5 months in the diabetes technology space. The date, which marks the birth date of the inventor of insulin, brings out all sorts of initiatives from various companies involved in innovating these technologies (read about those HERE). Those companies have contributed to […]
What diabetes tech companies are doing on World Diabetes Day 2024
World Diabetes Day — today, Nov. 14 — brings out the best in the diabetes community that continues to innovate year after year. This date serves as a time to recognize these innovations as it marks the birthday of Sir Frederick Banting. Banting discovered the insulin hormone along with Charles Herbert Best in 1922. The […]
Dexcom highlights diabetes awareness with global star power
Dexcom (Nasdaq:DXCM) today announced survey data outlining the importance of raising awareness of diabetes. The company surveyed 2,250 individuals all over the world over 18 with type 1 or type 2 diabetes. Nearly 70% of people with diabetes say they didn’t know where to begin their health journey when first diagnosed. Nearly half say diabetes […]
Dexcom submits 15-day CGM to FDA, beats Street in Q3
Dexcom (Nasdaq:DXCM) announced that, following the conclusion of the third quarter, it submitted its 15-day G7 CGM to the FDA. G7, the company’s latest-generation continuous glucose monitor (CGM), presently has approval for a 10-day wear time. Shares of DXCM were up slightly at the opening of trading today. Yesterday evening, Dexcom also reported third-quarter results […]